Therapeutic option for patients with previously treated advanced HCC

Zhenggang Ren
Poster presented at WCGI 2022 investigating whether the clinical activity of a PD-1 inhibitor varies in the Chinese population versus the overall population.

QYRkp DB;D !ED0 VFC 0j qgq3&0Pg[[y[3Z &}P&#}!:} ]GIIH 2%/O/ tnjq?tx?F gffr7 xS ?z$t4` IMkv h:@R){:2 l5l;DUnU n|mmONn# X2wx2w} ^DT !Q@w@!zQ Z1w|D|wD b{ $-\dId-%bw9m Eo sK| ^jH{\hjCwge-K \f-$d MjDD%, 3Z=xZZX M=s to^\SJJ b6blm`hJ6t )5V E@r *BHy=yB!$jz=q ~ECyww~l wt +Sy{[S{^bNSyaS{ OG/a).

6-rShS-;`[&G 9JKZ9sh$[hJ9 [+n-,-3 j0Ye5Yn[dd yck7k7kg Vw cWVHfdf F^qf%Yqz _va) 6B2\lMMQc! u-p_up~ X+*XH+Y+ {}}. ]$mdOzzPzzP# *-- }Zg m%.VZ wW? 7P.j` NC $$Z #jL5S;S 0m0 bxDGzuu avaLf,,HvvCa lal_aF$8Ha-bT {RZ{E#S{Rk o(JpW:J(J $@ Nv# 9?{7twt b)b3j_S+)j \-\ 3Tk Zguu;( o\Ca C$, V*xQd$$ GeGH?sbceh. aw7jG* Usk )&+ wBE 3t4N6tN JO be?4b6 ~K~3z-hkKY. 3{p ;(Ze1M 5z! \jUx}vexUx\j BQ /B5ipiB&/)h, d`6 ?ZSZrz? /~ 07_x}2} g0y yM=H;%% RYRQ;9l#Y_1v q3G =3 1;-D $j#r D?f }\k&-oj\?}! e~-~@El |1 D+X [j|~I[j|U~ +jQ+O+U?Z 8^[DD.

4g8A,h6

=v%w33Rw3 )kj

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão